Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate.
Thromb Haemost
; 82(4): 1247-9, 1999 Oct.
Article
in En
| MEDLINE
| ID: mdl-10544907
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Factor IX
/
Hemophilia B
/
Antibodies
Type of study:
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Child, preschool
/
Humans
/
Infant
Language:
En
Journal:
Thromb Haemost
Year:
1999
Document type:
Article
Affiliation country:
Francia
Country of publication:
Alemania